Loading...
Exploiting viral natural history for vaccine development
The partial successes of the Phase 2 gB-based vaccine trials for HCMV highlight the very real likelihood that vaccine-mediated induction of antibodies that neutralize the fusion pathway of fibroblast infection is not sufficient as a singular strategy to confer protective efficacy against primary HCM...
Na minha lista:
| Udgivet i: | Med Microbiol Immunol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4439440/ https://ncbi.nlm.nih.gov/pubmed/25794555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00430-015-0406-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|